Union Health Minister Mansukh Mandaviya on Tuesday said that the Central Drugs Standard Control Organisation (CDSCO) has approved the Serum Institute of India's COVID-19 vaccine Covovax, Biological......
Zydus Cadila's COVID-19 vaccine ZyCoV-D will initially be used in seven states, including Maharashtra, Tamil Nadu, Uttar Pradesh and West Bengal, which have been recommended to identify the......
Zydus Cadila has agreed to bring down the price of its COVID-19 vaccine to Rs 265 a dose following persistent negotiations by the government but a final deal is yet to be reached, sources said on......
With talks underway between the central government and Zydus Cadila over the pricing of the COVID-19 vaccine ZyCov-D, the pharma company is learnt to have proposed a price of Rs 1,900 for its......
Prime Minister Narendra Modi on Saturday said India has developed the world's first DNA vaccine against COVID-19, which can be administered to all people above the age of 12 years. 'India, which......
When compared to the domestic sales of April 2019, the growth is around 37 per cent. However, compared to the previous month (March), the growth is 18.4 per cent. IMAGE: Kindly note that this......
The growth was led by family-owned companies and business groups with presence in pharmaceuticals, information technology services, and consumer products. Illustration: Dominic Xavier/Rediff.com......
From rising prescriptions to the pharma sales force back on the field with full vigour and companies finally finding their feet with the digital marketing strategies — Indian drug makers have......
The government is considering setting up air freight stations to enable direct movement of vaccines from pharmaceutical factories to the aircraft. From reducing dwell time at airports to faster......
Indian drug firms like Marksans Pharma, Aurobindo Pharma, Zydus and Jubilant are recalling products in the US market, as per the latest enforcement report by the US Food and Drug......